The US Food and Drug Administration has also approved certain GLP-1 medications to treat obesity
Its a chronic disease that exacerbates cardiovascular conditions, already killing Black and brown Pennsylvanians at disproportionate rates
Pharmaceutical Research 2010
Int Urogynecol J
Gut Health, Leaky Gut Repair, and Systemic Inflammation Control Because BPC-157 originates from a gastric peptide, it also has regenerative effects on: Stomach lining (ulcers, gastritis) Intestinal barrier (tight junction restoration) Gut-brain signaling (mood, sleep, focus) This makes it particularly useful for: Athletes using NSAIDs or oral PEDs Individuals with IBS, IBD, or celiac Users with chronic bloating, fatigue, or GI inflammation Oral BPC-157 demonstrated potent anti-ulcer properties and restored epithelial integrity in models of induced intestinal inflammation. Petrovic et al., Inflammopharmacology 6
It has an approved indication for HIV-associated lipodystrophy